Rivastigmine Transdermal System is a Transdermal Patch, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Alvogen Inc.. The primary component is Rivastigmine.
| Product ID | 47781-304_07f534f5-5146-8b12-29b5-5a4992e43412 |
| NDC | 47781-304 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Rivastigmine Transdermal System |
| Generic Name | Rivastigmine Transdermal System |
| Dosage Form | Patch, Extended Release |
| Route of Administration | TRANSDERMAL |
| Marketing Start Date | 2015-09-04 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA204403 |
| Labeler Name | Alvogen Inc. |
| Substance Name | RIVASTIGMINE |
| Active Ingredient Strength | 5 mg/1 |
| Pharm Classes | Cholinesterase Inhibitor [EPC],Cholinesterase Inhibitors [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2019-12-31 |
| Marketing Start Date | 2015-09-04 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | ANDA |
| Application Number | ANDA204403 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2015-09-04 |
| Marketing Category | ANDA |
| Application Number | ANDA204403 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2015-09-04 |
| Ingredient | Strength |
|---|---|
| RIVASTIGMINE | 4.6 mg/1 |
| SPL SET ID: | 11d4ef03-33d2-359e-2053-4102630b27ba |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 47781-304 | Rivastigmine Transdermal System | Rivastigmine Transdermal System |
| 47781-305 | Rivastigmine Transdermal System | Rivastigmine Transdermal System |
| 47781-405 | Rivastigmine Transdermal System | Rivastigmine Transdermal System |
| 51991-897 | Rivastigmine Transdermal System | Rivastigmine |
| 51991-898 | Rivastigmine Transdermal System | Rivastigmine |
| 51991-899 | Rivastigmine Transdermal System | Rivastigmine |
| 63629-2064 | Rivastigmine Transdermal System | Rivastigmine |
| 63629-2065 | Rivastigmine Transdermal System | Rivastigmine |
| 63629-2066 | Rivastigmine Transdermal System | Rivastigmine |
| 63629-8807 | Rivastigmine Transdermal System | Rivastigmine |
| 63629-8846 | Rivastigmine Transdermal System | Rivastigmine |
| 72855-100 | Rivastigmine Transdermal System | Rivastigmine |
| 72855-102 | Rivastigmine Transdermal System | Rivastigmine Transdermal System |
| 72855-101 | Rivastigmine Transdermal System | Rivastigmine Transdermal System |